Probiotic IBNI617 for Moderate to Severe Depression: A Randomized Controlled Trial | MicrobiomeTrials← Back to trialsNCT07728253
Probiotic IBNI617 for Moderate to Severe Depression: A Randomized Controlled Trial
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-08Est. Completion: 2027-12
Enrollment target: 148 participants Locations- Shanghai Mental Health Center, Shanghai, China
Other microbiome trials you might be interested in
Bipolar I Disorder
Phase II study for patients with Bipolar 1 Disorder experiencing major depressive episode. Patient eligible for enrollme…
Bentonville, United StatesEst. completion Feb 2028
Major Depressive Disorder (MDD)Depressive EpisodesDepressive Syndrome
The goal of this clinical trial is to compare two maintenance transcranial magnetic stimulation (rTMS) strategies follow…
Munich, GermanyEst. completion Sep 30, 2028
Major Depressive DisorderBipolar DisorderSchizophrenia
This prospective, open-label clinical trial aims to compare a novel "Venous Tourniquet with Regional Low-Dose Sugammadex…
Istanbul, Turkey (Türkiye)Est. completion Nov 30, 2026